EichorEICHOR
Study identifier: NCT06066528 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Completed

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Condition: Obesity · Diabetes Mellitus, Type 2  ·  Sponsor: Boehringer Ingelheim

PhasePhase 3
Planned participants755
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is open to adults who are at least 18 years old and have a body mass index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exercise or with specific diabetes medications. Only people who have previously not managed to lose weight by changing their diet can participate. The purpose of this study is to find out whether a medicine called survodutide (BI 456906) helps people living with overweight or obesity who also have diabetes to lose weight. Participants are divided into 3 groups by chance, like drawing names from a hat. 2 groups get different doses of survodutide and 1 group gets placebo. Placebo looks like survodutide but does not contain any medicine. Every participant has a 2 in 3 chance of getting survodutide. Participants inject survodutide or placebo under their skin once a week for about one and a half years. In addition to the study medicine, all participants receive counselling to make changes to their diet and to exercise regularly. Participants are in the study for about 1 year and 7 months. During this time, it is planned that participants visit the study site up to 14 times and receive 6 phone calls by the site staff. The doctors check participants' health and take note of any unwanted effects. The study staff also regularly measure participants' body weight. The results are compared between the groups to see whether the treatment works.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (143)

Pinnacle Research Group, LLCAnniston, Alabama, United States
EmVenio Research-Atlanta-69582Phoenix, Arizona, United States
Encompass Clinical Research, Spring ValleySpring Valley, California, United States
Diablo Clinical ResearchWalnut Creek, California, United States
Alliance for Multispecialty Research, LLC - DoralDoral, Florida, United States
University of FloridaGainesville, Florida, United States
East Coast Institute for Research, LLC - JacksonvilleJacksonville, Florida, United States
New Horizon Research Center-Miami-69732Miami, Florida, United States
West Orange EndocrinologyOcoee, Florida, United States
Emory UniversityAtlanta, Georgia, United States
East-West Medical ResearchHonolulu, Hawaii, United States
Solaris Clinical ResearchMeridian, Idaho, United States

+ 131 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →